$5.52 -0.18 (-3.16%)
11/27/2009 1:00 PM

ZymoGenetics, Inc. (ZGEN)

CAPS Rating: 3 out of 5

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Featured Broker Partners